Severe acute diarrhea

Gastroenterology Clinics of North America

Volumn 32, Issue 4, 2003, Pages 1249-1267

  Gore, Julia I ^a   Surawicz, Christina ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ATTAPULGITE; BICARBONATE; BISMUTH SALICYLATE; COLCHICINE; DIPHENOXYLATE; ENKEPHALINASE INHIBITOR; LAXATIVE; LOPERAMIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SORBITOL;

ACUTE DIARRHEA; DISEASE SEVERITY; ENDEMIC DISEASE; ENTERITIS; FECES ANALYSIS; FEVER; FOOD HANDLING; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INTESTINE ISCHEMIA; INTRAVENOUS ADMINISTRATION; OCCUPATIONAL HAZARD; ORAL REHYDRATION THERAPY; RADIATION ENTEROPATHY; REVIEW; SIDE EFFECT; TRAVEL;

EID: 0346219433     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00100-6     Document Type: Review

References (150)

1. Cohen ML. The epidemiology of diarrheal disease in the United States. Infect Dis Clin North Am 1988;2:557-70.
2. Torrens, PR, Historical evolution and overview of health services in the United States. In: Williams SJ, editor. Introduction to health science. 6th edition. Albany (NY): Delmar; 2002.
3. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 1992;70:705-14.
4. Yip R, Sharp TW. Acute malnutrition and high childhood mortality related to diarrhea: lessons from the 1991 Kurdish refugee crisis. JAMA 1993;270:587-90.
5. Feldman RA, Banatvala N. The frequency of culturing stools from adults with diarrhoea in Great Britain. Epidemiol Infect 1994;113:41-4.
6. Gangarosa RE, Glass RI, Lew JF, Boring JR. Hospitalizations involving gastroenteritis in the United States, 1985: the special burden of the disease among the elderly. Am J Epidemiol 1992;135:281-90.
7. Lew JF, Glass RI, Gangarosa RE, Cohen IP, Bern C, Moe CL. Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA 1991; 265:3280-4.
8. DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1997; 92:1962-75.
9. Manatsathit S, Dupont HL, Farthing M, et al. Guideline for the management of acute diarrhea in adults. J Gastroenterol Hepatol 2002;17:S54-S71.
10. Wenzl HH, Fine KD, Schiller LR, Fordtran JS. Determinants of decreased fecal consistency in patients with diarrhea. Gastroenterology 1995;108:1729-38.
11. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol 1994;89:1160-4.
12. Schiller L, Sellin J. Diarrhea. In: Feldman LF, Sleisenger M, editors. Gastrointestinal and liver disease, vol. I. 7th edition. Philadelphia: WB Saunders; 2002.
13. Park SI, Giannella RA. Approach to the adult patient with acute diarrhea. Gastroenterol Clin North Am 1993;22:483-97.
14. Ramakrishna BS, Kang G, Rajan DP, Mathan M, Mathan VI. Isolation of Vibrio cholerae O139 from the drinking water supply during an epidemic of cholera. Trop Med Int Health 1996;1:854-8.
15. Goodgame R. Emerging causes of traveler's diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia. Curr Infect Dis Rep 2003;5:66-73.
16. Castelli F, Pezzoli C, Tomasoni L. Epidemiology of travelers' diarrhea. J Travel Med 2001;8(suppl 2):S26-30.
17. Sohn N, Robilotti JG Jr. The gay bowel syndrome: a review of colonic and rectal conditions in 200 male homosexuals. Am J Gastroenterol 1977;67:478-84.
18. Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR Recomm Rep 2001;50(RR-2):1-69.
19. Mange K, Matsuura D, Cizman B, et al. Language guiding therapy: the case of dehydration versus volume depletion. Ann Intern Med 1997;127:848-53.
20. McGee S, Abernethy WB III, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA 1999;281:1022-9.
21. Reardon M, Coleman P, Twomey C, Hyland CM. Rectal examination in hospital patients. Ir Med J 1995;88:220-1.
22. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25.
23. Koplan JP, Fineberg HV, Ferraro MJ, Rosenberg ML. Value of stool cultures. Lancet 1980;2:413-6.
24. Barbut F, Leluan P, Antoniotti G, Collignon A, Sedallian A, Petit JC. Value of routine stool cultures in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis 1995;14:346-9.
25. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990;263:979-82.
26. de Wit MA, Hoogenboom-Verdegaal AM, Goosen ES, Sprenger MJ, Borgdorff MW. A population-based longitudinal study on the incidence and disease burden of gastroenteritis and Campylobacter and Salmonella infection in four regions of The Netherlands. Eur J Epidemiol 2000;16:713-8.
27. CDC. FoodNet (CDC) Annual Report Part I. http://www.cdc.gov//foodnet. Accessed June 2003.
28. Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R. Etiological agents of infectious diarrhea: implications for requests for microbial culture. J Clin Microbiol 1997;35:1427-32.
29. McNeely WS, Dupont HL, Mathewson JJ, Oberhelman RA, Ericsson CD. Occult blood versus fecal leukocytes in the diagnosis of bacterial diarrhea: a study of US travelers to Mexico and Mexican children. Am J Trop Med Hyg 1996;55:430-3.
30. Harris JC, Dupont HL, Hornick RB. Fecal leukocytes in diarrheal illness. Ann Intern Med 1972;76:697-703.
31. Bauer TM, Lalvani A, Fehrenbach J, et al. Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA 2001;285:313-9.
32. Lew JF, LeBaron CW, Glass RI, et al. Recommendations for collection of laboratory specimens associated with outbreaks of gastroenteritis. MMWR Recomm Rep 1990; 39(RR-14):1-13.
33. Barbut F, Beaugerie L, Delas N, Fossati-Marchal S, Aygalenq P, Petit JC. Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients. Infectious Colitis Study Group. Clin Infect Dis 1999; 29:356-60.
34. Gandhi SK, Hanson MM, Vernava AM, Kaminski DL, Longo WE. Ischemic colitis. Dis Colon Rectum 1996;39:88-100.
35. Mantzaris GJ, Hatzis A, Archavlis E, et al. The role of colonoscopy in the differential diagnosis of acute, severe hemorrhagic colitis. Endoscopy 1995;27:645-53.
36. Faruque SM, Nair GB. Molecular ecology of toxigenic Vibrio cholerae. Microbiol Immunol 2002;46:59-66.
37. Steinberg EB, Greene KD, Bopp CA, Cameron DN, Wells JG, Mintz ED. Cholera in the United States, 1995-2000: trends at the end of the twentieth century. J Infect Dis 2001;184:799-802.
38. Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound-Connecticut, New Jersey, and New York, 1998. MMWR Morb Mortal Wkly Rep 1999;48:48-51.
39. Bhattacharya SK, Bhattacharya MK, Nair GB, et al. Clinical profile of acute diarrhoea cases infected with the new epidemic strain of Vibrio cholerae O139: designation of the disease as cholera. J Infect 1993;27:11-5.
40. Schiraldi O, Benvestito V, Di Bari C, Moschetta R, Pastore G. Gastric abnormalities in cholera: epidemiological and clinical considerations. Bull World Health Organ 1974; 51:349-52.
41. Morris JG Jr, Black RE. Cholera and other vibrioses in the United States. N Engl J Med 1985;312:343-50.
42. Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections: clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 1988;109:318-23.
43. McArthur J. The rapid diagnosis of cholera. J Trop Med Hyg. 1977;80:99-101.
44. Lesmana M, Richie E, Subekti D, Simanjuntak C, Walz SE. Comparison of direct-plating and enrichment methods for isolation of Vibrio cholerae from diarrhea patients. J Clin Microbiol 1997;35:1856-8.
45. Seas C, DuPont HL, Valdez LM, Gotuzzo E. Practical guidelines for the treatment of cholera. Drugs 1996;51:966-73.
46. Gotuzzo E, Seas C, Echevarria J, Carrillo C, Mostorino R, Ruiz R. Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults. Clin Infect Dis 1995;20:1485-90.
47. CDC. Foodnet surveillance report for 2000. Centers for Disease Control and Prevention. Available at: www.cdc.gov/foodnet. Accessed May 2003.
48. Friedman C. Risk factors for sporadic Campylobacter infections in the United States: a case-control study on FoodNet sites. Presented at the International Conference on Emerging Infectious Diseases. Atlanta, GA, July 2000.
49. Mishu B, Blaser MJ. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barrésyndrome. Clin Infect Dis 1993;17:104-8.
50. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacterjejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118: 947-53.
51. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001;32:1201-6.
52. Kulkarni SP, Lever S, Logan JM, Lawson AJ, Stanley J, Shafi MS. Detection of campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol 2002;55:749-53.
53. Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995;21:536-41.
54. Pai CH, Gillis F, Tuomanen E, Marks MI. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child 1983;137:286-8.
55. Petruccelli BP, Murphy GS, Sanchez JL, et al. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992;165:557-60.
56. Segreti J, Gootz TD, Goodman LJ, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992;165:667-70.
57. Chalker RB, Blaser MJ. A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis 1988;10:111-24.
58. Cherubin CE, Neu HC, Imperato PJ, Harvey RP, Bellen N. Septicemia with non-typhoid salmonella. Medicine (Baltimore) 1974;53:365-76.
59. Nelson SJ, Granoff D. Salmonella gastroenteritis in the first three months of life: a review of management and complications. Clin Pediatr (Phila) 1982;21:709-12.
60. Thuluvath PJ, McKendrick MW. Salmonella and complications related to age: Sheffield experience. Q J Med 1988;67:497-503.
61. Mandal BK, Brennand J. Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit. BMJ 1988;297:1242-3.
62. Han T, Sokal JE, Neter E. Salmonellosis in disseminated malignant diseases: a seven-year review (1959-1965). N Engl J Med 1967;276:1045-52.
63. Shimoni Z, Pitlik S, Leibovici L, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999; 28:822-7.
64. Samra Y, Shaked Y, Maier MK. Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1986;8:431-40.
65. Lockyer WA, Feinfeld DA, Cherubin CE, Carvounis G, Iancu M, Avram MM. An outbreak of Salmonella enteritis and septicemia in a population of uremic patients: a review of four cases, including infection of an arteriovenous fistula. Arch Intern Med 1980;140:943-5.
66. Wright J, Thomas P, Serjeant GR. Septicemia caused by Salmonella infection: an overlooked complication of sickle cell disease. J Pediatr 1997;130:394-9.
67. Schutze GE, Schutze SE, Kirby RS. Extraintestinal salmonellosis in a children's hospital. Pediatr Infect Dis J 1997;16:482-5.
68. Sirinavin S, Garner P. Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev 2000;2:CD001167.
69. Threlfall EJ, Ward LR, Skinner JA, Smith HR, Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999;353:1590-1.
70. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989; 159:1126-8.
71. Azim T, Rashid A, Qadri F, et al. Antibodies to Shiga toxin in the serum of children with Shigella-associated haemolytic uraemic syndrome. J Med Microbiol 1999;48:11-6.
72. Bhimma R, Rollins NC, Coovadia HM, Adhikari M. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 1997;11:560-4.
73. Stieglitz H, Fosmire S, Lipsky P. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum 1989;32:937-46.
74. Altwegg M, Buser J, von Graevenitz A. Stool cultures for Shigella spp: improved specificity by using MacConkey agar with xylose. Diagn Microbiol Infect Dis 1996;24:121-4.
75. DuPont HL. Progress in therapy for infectious diarrhea. Scand J Gastroenterol Suppl 1989;169:1-3.
76. Haltalin KC, Nelson JD, Hinton LV, Kusmiesz HT, Sladoje M. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis: a double-blind study with ampicillin and neomycin. J Pediatr 1968;72:708-20.
77. Van Noyen R, Selderslaghs R, Bekaert J, Wauters G, Vandepitte J. Causative role of Yersinia and other enteric pathogens in the appendicular syndrome. Eur J Clin Microbiol Infect Dis 1991;10:735-41.
78. Ackers ML, Schoenfeld S, Markman J, et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis 2000;181:1834-7.
79. Schiemann DA. Synthesis of a selective agar medium for Yersinia enterocolitica. Can J Microbiol 1979;25:1298-304.
80. Jimenez-Valera M, Gonzalez-Torres C, Moreno E, Ruiz-Bravo A. Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica 09 infection in mice. Antimicrob Agents Chemother 1998;42:3009-11.
81. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995;23:295-305.
82. Borriello SP, Barclay FE. Clostridium difficile in the elderly. J Infect 1991;22:310-2.
83. Lesna M, Parham DM. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment: mortality due to C difficile colitis in elderly people has been underestimated. BMJ 1996;312:778.
84. Impallomeni M, Galletly NP, Wort SJ, Starr JM, Rogers TR. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. BMJ 1995;311: 1345-6.
85. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: a review. Arch Intern Med 2001;161:525-33.
86. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43-50.
87. Yassin SF, Young-Fadok TM, Zein NN, Pardi DS. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc 2001;76:725-30.
88. Cone JB, Wetzel W. Toxic megacolon secondary to pseudomembranous colitis. Dis Colon Rectum 1982;25:478-82.
89. Mundy LS, Shanholtzer CJ, Willard KE, Gerding DN, Peterson LR. Laboratory detection of Clostridium difficile: a comparison of media and incubation systems. Am J Clin Pathol 1995;103:52-6.
90. Peterson LR, Kelly PJ, Nordbrock HA. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 1996;15:330-6.
91. Bergstein JM, Kramer A, Wittman DH, Aprahamian C, Quebbeman EJ. Pseudomembranous colitis: how useful is endoscopy? Surg Endosc 1990;4:217-9.
92. Brar HS, Surawicz CM. Pseudomembranous colitis: an update. Can J Gastroenterol 2000;14:51-6.
93. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
94. Mylotte JM, Graham R, Kahler L, Young L, Goodnough S. Epidemiology of nosocomial infection and resistant organisms in patients admitted for the first time to an acute rehabilitation unit. Clin Infect Dis 2000;30:425-32.
95. Cartmill TD, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 1994;27:1-15.
96. Sims RV, Hauser RJ, Adewale AO, et al. Acute gastroenteritis in three community-based nursing homes. J Gerontol A Biol Sci Med Sci 1995;50:M252-6.
97. Talan D, Moran GJ, Newdow M, et al. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. Clin Infect Dis 2001;32:573-80.
98. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995;333:364-8.
99. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151:775-82.
100. Su C, Brandt LJ. Escherichia coli O157:H7 infection in humans. Ann Intern Med 1995;123:698-714.
101. March SB, Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 1986;23:869-72.
102. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 1990;116:544-51.
103. Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 1992;20:25-9.
104. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections. N Engl J Med 2000;342:1930-6.
105. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157 H7 in Washington State. The first year of statewide disease surveillance. JAMA 1989;262:355-9.
106. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med 1999; 106:670-6.
107. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991;325:252-64.
108. Steinhoff MC, Douglas RG Jr, Greenberg HB, Callahan DR. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 1980;78:1495-9.
109. Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997;336:1548-56.
110. Bartlett JG, Belitsos PC, Sears CL. AIDS enteropathy. Clin Infect Dis 1992;15:726-35.
111. Asmuth DM, DeGirolami PC, Federman M, et al. Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis 1994;18:819-25.
112. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994;107: 1398-407.
113. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG. Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS 1992;6:1495-8.
114. Buckell NA, Williams GT, Bartram CI, Lennard-Jones JE. Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. Gastroenterology 1980;79:19-25.
115. Ludwig D, Stange EF. Treatment of ulcerative colitis. Hepatogastroenterology 2000;47: 83-9.
116. Nicholls RJ. Review article: ulcerative colitis-surgical indications and treatment. Aliment Pharmacol Ther 2002;16(suppl 4):25-8.
117. Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Saf 2000;22:53-72.
118. Bismar MM, Sinicrope FA. Radiation enteritis. Curr Gastroenterol Rep 2002;4:361-5.
119. Alapati SV, Mihas AA. When to suspect ischemic colitis. Why is this condition so often missed or misdiagnosed? Postgrad Med 1999;105:177-87.
120. Duggan C, Santosham M, Glass RI. The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention. MMWR Recomm Rep 1992;41(RR-16):1-20.
121. Avery ME, Snyder JD. Oral therapy for acute diarrhea: the underused simple solution. N Engl J Med 1990;323:891-4.
122. Carpenter CC, Greenough WB, Pierce NF. Oral-rehydration therapy: the role of polymeric substrates. N Engl J Med 1988;319:1346-8.
123. de Zoysa I, Kirkwood B, Feachem R, Lindsay-Smith E. Preparation of sugar-salt solutions. Trans R Soc Trop Med Hyg 1984;78:260-2.
124. Rahman O, Bennish ML, Alam AN, Salam MA. Rapid intravenous rehydration by means of a single polyelectrolyte solution with or without dextrose. J Pediatr 1988;113:654-60.
125. Bennett RG, Greenough WB III. Approach to acute diarrhea in the elderly. Gastroenterol Clin North Am 1993;22:517-33.
126. Duggan C, Nurko S. "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr 1997;131:801-8.
127. Wistrom J, Jertborn M, Ekwall E, et al. Empiric treatment of acute diarrheal disease with norfloxacin: a randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med 1992;117:202-8.
128. Oldfield EC III, Wallace MR. The role of antibiotics in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001;30:817-36.
129. DuPont HL, Ericsson CD, Robinson A, Johnson PC. Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med 1987;82:324-8.
130. DuPont HL, Marshall GD. HIV-associated diarrhoea and wasting. Lancet 1995;346: 352-6.
131. DuPont HL, Reves RR, Galindo E, Sullivan PS, Wood LV, Mendiola JG. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med 1982;307:841-4.
132. Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea: a placebo-controlled, randomized trial. Ann Intern Med 1987;106:216-20.
133. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-7.
134. Bergstrom T, Alestig K, Thoren K, Trollfors-B. Symptomatic treatment of acute infectious diarrhoea: loperamide versus placebo in a double-blind trial. J Infect 1986;12:35-8.
135. van Loon FP, Bennish ML, Speelman P, Butler C. Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut 1989;30:492-5.
136. DuPont HL, Hornick RB. Adverse effect of lomotil therapy in shigellosis. JAMA 1973;226:1525-8.
137. Murphy GS, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 1993;118:582-6.
138. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984;86:1475-80.
139. Lustman F, Walters EG, Shroff NE, Akbar FA. Diphenoxylate hydrochloride (Lomotil) in the treatment of acute diarrhoea. Br J Clin Pract 1987;41:648-51.
140. Cimolai N, Carter JE, Morrison BJ, Anderson JD. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr 1990;116: 589-92.
141. DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, DuPont MW, de la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347-50.
142. Ericsson CD, Evans DG, DuPont HL, Evans DJ Jr, Pickering LK. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis. Nov 1977;136(5):693-6.
143. Graham DY, Estes MK, Gentry LO. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology 1983;85:1017-22.
144. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977;73(4 pt 1):715-8.
145. Leber W. A new suspension form of smectite (Liquid 'Diasorb') for the treatment of acute diarrhoea: a randomized comparative study. Pharmatherapeutica 1988;5:256-60.
146. Zaid MR, Hasan M, Khan AA. Attapulgite in the treatment of acute diarrhoea: a double-blind placebo-controlled study. J Diarrhoeal Dis Res 1995;13:44-6.
147. DuPont HL, Ericsson CD, DuPont MW, Cruz Luna A, Mathewson JJ. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am J Med 1990;88:20S-3S.
148. Okhuysen PC, DuPont HL, Ericsson CD, et al. Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial. Clin Infect Dis 1995;21:341-4.
149. Hamza H, Ben Khalifa H, Baumer P, Berard H, Lecomte JM. Racecadotril versus placebo in the treatment of acute diarrhoea in adults. Aliment Pharmacol Ther 1999;13(suppl 6): 15-9.
150. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med 2000;343:463-7.